Republican voters in the early primary states of Iowa and New Hampshire do not believe that the incoming administration ought to interfere with the enactment of state laws legalizing marijuana, according to polling data conducted by Public Policy Polling and published today by Marijuana-Majority.com.
Sixty-seven percent of GOP voters in New Hampshire agree that “states should be able to carry out their own marijuana laws without federal interference.” Sixty-four percent of Iowa GOP voters agreed with the statement.
This voter sentiment is contrary to the public positions of at least two Republican Presidential candidates, New Jersey Gov. Chris Christie and Florida Senator Marco Rubio — both of whom have espoused using the power of the federal government to roll back changes in state marijuana laws.
Overall, a super-majority of all voters in Iowa (71 percent) and New Hampshire (73 percent) oppose federal interference in state laws permitting marijuana use.
Previous polls surveying a national sampling of voters have reported similar results. Gallup pollsters reported that 64 percent of respondents oppose federal interference in state laws that allow for the legal use of the cannabis by adults, while a Third Way commissioned poll found that six out of ten voters believe that states, not the federal government, should authorize and enforce marijuana policy. Most recently, a 2015 Pew poll reported that a strong majority Americans — including 64 percent of Independents, 58 percent of Democrats, and 54 percent of Republicans — believe that the federal government should not enforce laws in states that allow marijuana use.
Republican Gov. Bruce Rauner on Friday issued an amendatory veto to House Bill 218, which seeks to decriminalize minor marijuana possession offenses.
As initially approved by the legislature in May, HB 218 reduced personal use possession penalties (up to 15 grams) from a Class A criminal misdemeanor, punishable by up to 6 months in jail, a $1,500 fine, and a criminal record, to a petty offense, punishable by a fine only (up to $125.00) – no arrest, and no criminal record. Governor Rauner’s amendatory veto seeks to decrease the proposed possession limits from 15 grams to 10 grams, whole also seeking to raise fines to $200.00.
Governor Rauner also seeks to lower the state’s proposed per se THC/blood limit from 15ng/ml to 5ng/ml. Under present Illinois law, drivers with any detectable amount of THC in their blood are in violation of the state’s traffic safety laws.
If a majority of lawmakers fail to approve of the Governor’s amendments, the measure will be dead for this year’s legislative session.
To date, 20 states and Washington, DC have passed legislation eliminating the threat of incarceration for marijuana possession offenses via either legalization or decriminalization.
A history of cannabis use is associated with a lower likelihood of obesity and diabetes, according to population-based data published in the journal Obesity.
Investigators from the Conference of Quebec University Health Centers assessed cannabis use patterns and body mass index (BMI) in a cohort of 786 Inuit (Arctic aboriginal) adults ages 18 to 74. Researchers reported that subjects who consumed cannabis in the past year were more likely to possess a lower BMI, lower fasting insulin, and lower HOMA-IR (insulin resistance) as compared to those who did not use the substance.
Specifically, researchers reported that cannabis users possessed an average BMI of 26.8 compared to an index of 28.6 for non-users, after controlling for age, gender and other factors. Those subjects who reported using cannabis but never having used tobacco, or who were former users of tobacco, possessed on average the lowest BMI.
Authors concluded: “In this large cross-sectional adult survey with high prevalence of both substance use and obesity, cannabis use in the past year was associated with lower BMI, lower percentage fat mass, lower fasting insulin, and HOMA-IR. … The inverse association observed in our work supports evidence from a larger proportion of previous cross-sectional and follow-up investigations. … As a result, cannabinoids from cannabis may be viewed as an interesting avenue for research on obesity and associated conditions.”
Observational trial data published in 2013 in the American Journal of Medicine reported that subjects who consumed cannabis possessed favorable indices related to diabetic control compared to those without a history of recent marijuana use. Separate observational trial data published in 2012 in the British Medical Journal reported that marijuana users had a lower prevalence of type 2 diabetes and possessed a lower risk of contracting the disease than did those with no history of cannabis consumption, even after researchers adjusted for social variables such as subjects’ ethnicity, family history, and levels of physical activity.
Cross-sectional data published in 2011 in the American Journal of Epidemiology similarly reported that the prevalence of obesity in the general population is sharply lower among marijuana consumers than it is among nonusers.
National Council of State Legislatures Passes Resolution “In Support of States Determining Their Own Marijuana and Hemp Policies”August 7, 2015
The National Council of State Legislatures passed a resolution yesterday urging the federal government to amend the Controlled Substances Act and to refrain from interfering with state laws permitting the legal production and use of cannabis.
The National Council of State Legislatures is a bipartisan, non-governmental organization founded in 1975 to unite members of legislature’s from around the United States. The council works to improve the quality and effectiveness of state legislatures, promote innovative policy and communication among state legislatures, and to magnify their voice in the federal system.
The NCSL resolves “[S]tates and localities should be able to set whatever marijuana and hemp policies work best to improve the public safety, health, and economic development of their communities.” Members passed the resolution overwhelmingly by a voice vote.
The vote represents a strong consensus among state lawmakers that the federal government should embrace, not impede the progress states have made to amend their marijuana laws, and encourages federal lawmakers to consider rescheduling marijuana in order for states to safely and effectively move forward in their reforms.
Currently 23 states and the District of Columbia have medical marijuana laws on the books, and half of all US states recognize industrial hemp. Four states plus Washington D.C. have legalized marijuana for recreational use. There is no doubt states have recognized the failed efforts of marijuana prohibition and are eager to try out other policies. NORML commends the resolution adopted by the National Council of State Legislatures and will continue to advocate for the federal government’s compliance.
Newly appointed head of the Drug Enforcement Administration (DEA), Chuck Rosenberg, says that marijuana is “probably” not as dangerous as heroin.
Rosenberg’s comments, issued Tuesday, are seemingly in conflict with marijuana’s Schedule I classification under federal law, which places it in the same category as heroin and is a lesser category than cocaine. The law defines cannabis and its dozens of distinct cannabinoids as possessing “a high potential for abuse … no currently accepted medical use, … [and] a lack of accepted safety for the use of the drug … under medical supervision.”
Predictably, Rosenberg did emphasize that he believed cannabis posed potential harms, stating:“If you want me to say that marijuana’s not dangerous, I’m not going to say that because I think it is. Do I think it’s as dangerous as heroin? Probably not. I’m not an expert.”
However, Rosenberg acknowledged that he has asked DEA offices “to focus their efforts and the resources of the DEA on the most important cases in their jurisdictions, and by and large what they are telling [him] is that the most important cases in their jurisdictions are opioids and heroin.”
Rosenberg’s predecessor, Michelle Leonhart vigorously defended marijuana’s Schedule I classification. She oversaw dozens of raids on medical marijuana providers, criticized the President on his remarks of marijuana’s safety in relation to alcohol, and rejected an administrative petition calling for marijuana rescheduling hearings. NORML is pleased that although the new DEA administrator, by his own admission is not “an expert” on cannabis, he apparently possesses a better grasp on marijuana and it’s evident differences compared to other schedule 1 substances.
Rosenberg’s comments, coupled with those of NIDA Director Nora Volkow publically espousing the safety of CBD indicate that it may no longer be a question of if the federal government will move to reclassify cannabis but when.